Maarten W. Nijsten

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial

Evelien de Jong, Jos A van Oers, Albertus Beishuizen et al. · The Lancet Infectious Diseases · 2016 · 825 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

Hyperglycaemic index as a tool to assess glucose control: a retrospective study

Mathijs Vogelzang, Iwan CC van der Horst, Maarten W. Nijsten · Critical Care · 2004 · 506 citations · Full text

Medicine, Internal Medicine, Diabetology +13

Clinical use of lactate monitoring in critically ill patients

Jan Bakker, Maarten W. Nijsten, Tim C. Jansen · Annals of Intensive Care · 2013 · 464 citations · Full text

Life Sciences, Physiology, Critical Care Pharmacology +14

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

Maarten W. Nijsten, Peter Olinga, Hauw The et al. · Critical Care Medicine · 2000 · 296 citations

Veterinary Medicine, Immunology, Pathology +15

Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers

Sanna op den Dries, Negin Karimian, Michael E. Sutton et al. · American Journal of Transplantation · 2013 · 287 citations

Medicine, Biomedical Engineering, Surgery +16